Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab.

ABSTRACT: Importance:Understanding adoption of new cancer therapies may help identify opportunities to increase use for high-value indications. Objective:To determine whether use of bevacizumab in 2005 to 2006 by oncologists' peers was associated with greater bevacizumab use among oncologists in 2007 to 2010. Design, Setting, and Participants:This cohort study of physicians and their patients took place in 51 randomly selected hospital referral regions in the United States. Participants were 44 012 fee-for-service Medicare beneficiaries aged 65 years or older with cancers of the colorectum, lung, breast, kidney, brain, or ovary treated by 3261 oncologists in 2005 to 2010 and assigned to one of 252 communities. Data were analyzed in 2017 to 2018. Exposures:Among patients treated with chemotherapy dur

SUBMITTER: Keating NL 

PROVIDER: S-EPMC6991243 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature